Company Monitoring Page for Sun-Pharma

latest headlines for company on cafepharma

On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
Fierce Pharma
Mon, 03/10/25 - 11:15 am
Tags:
Sun Pharma, Checkpoint Therapeutics, M&A, Unloxcyt
India's Sun Pharma aims to launch its obesity drug in five years, managing director says
MSN/Reuters
Mon, 03/3/25 - 10:11 am
Tags:
Sun Pharma, India, obesity, diabetes
Incyte blocks US launch of Sun Pharma's alopecia drug
Pharmaphorum
Mon, 11/4/24 - 11:10 am
Tags:
Incyte, Sun Pharma, Leqselvi, alopecia areata
Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India
Reuters
Fri, 06/21/24 - 11:02 am
Tags:
Takeda, Sun Pharma, Cipla, India, GERD, vonoprazan
India's Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mln
Reuters
Thu, 01/18/24 - 05:18 pm
Tags:
Sun Pharma, Taro, M&A
AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players
Fierce Pharma
Wed, 11/22/23 - 11:39 am
Tags:
AbbVie, Rinvoq, patents, legal, Sandoz, Sun Pharma, Intas Pharmaceuticals
Biopharma Confronts a Rising Tide of Ransomware Attacks
BioSpace
Wed, 06/14/23 - 10:11 am
Tags:
cyberattacks, cybersecurity, ransomware, Eisai, Sun Pharma, Novartis, AstraZeneca, Merck
Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Tags:
Novartis, Chinook Therapeutics, Paratek, Sobi, CTI BioPharma, Astellas, Iveric Bio, Assertio Holdings, Spectrum Pharmaceuticals, Merck, Prometheus Biosciences, Pfizer, Seagen, Sanofi, Provention Bio, Sun Pharma, Concert Pharmaceuticals, BioNTech, InstaDeep, AstraXeneca, CinCor Pharma, Ipsen, Albireo, Chiesi, Amryt, Moderna Therapeutics, OriCiro Genomics
Persistent Sun Pharma ready to complete Taro buyout—16 years after initial offer
Fierce Pharma
Tue, 05/30/23 - 11:27 am
Tags:
Sun Pharma, M&A, Taro Pharmaceuticals, India
FDA halts Sun Pharma's trials on dermatological drug
Pharma Live
Wed, 05/3/23 - 11:27 am
Tags:
Sun Pharma, clinical trials, dermatology, deuruxolitinib
Sun's Concert hits bum note as FDA imposes partial hold 2 months after $576M buyout
Fierce Biotech
Tue, 05/2/23 - 10:19 am
Tags:
Sun Pharma, Concerta Pharmaceuticals, M&A, FDA
Sun Pharma, Taro Pharmaceutical reach $75M settlement agreement in alleged price fixing scheme
Endpoints
Tue, 03/14/23 - 10:54 am
Tags:
Sun Pharma, Taro Pharmaceuticals, legal, price fixing
Sun Pharma issues recall for more than 34,000 bottles of blood pressure medication
Endpoints
Mon, 02/13/23 - 10:01 pm
Tags:
Sun Pharma, generics, product recalls, Diltiazem, hypertension
Sun Pharma to purchase Concert Pharmaceuticals for $576M
Medical Marketing and Media
Thu, 01/19/23 - 10:51 am
Tags:
Sun Pharma, Concert Pharmaceuticals, M&A, deuterium
FDA cites Sun Pharma with litany of GMP violations, including poor aseptic practices
RAPS.org
Wed, 01/11/23 - 11:05 pm
Tags:
FDA, Sun Pharma, drug manufacturing
Aurinia Pharma, Sun Pharma enter into settlement agreement for dry eye disease drug
Medical Dialogues
Wed, 01/4/23 - 09:41 am
Tags:
Aurinia Pharmaceuticals, Sun Pharma, dry eye disease, Cequa
FDA halts imports of several Sun Pharma drugs made in India due to outstanding quality issues
Endpoints
Fri, 12/9/22 - 10:27 am
Tags:
Sun Pharma, India, FDA, drug importation
Sun, Camber join growing list of companies reporting Adderall supply problems
Fierce Pharma
Fri, 10/7/22 - 10:50 am
Tags:
ADHD, Adderall, drug shortages, Sandoz, Sun Pharma, Novartis
Sun Pharma forks over $485M to settle long-running legal battle inherited in Ranbaxy buyout
Fierce Pharma
Thu, 03/24/22 - 08:40 pm
Tags:
Sun Pharma, legal, Ranbaxy, M&A
India's hesitance to condemn Russia puts the country's pharma industry in compromising position
Fierce Pharma
Wed, 03/9/22 - 12:00 pm
Tags:
Russia, Ukraine, India, Cipla, Dr Reddy's, Torrent Pharmaceuticals, Sun Pharma

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.